Centre asks Serum Institute, Bharat Biotech to lower Covid vaccines’ price
The central government on Monday asked the Serum Institute and Bharat Biotech to lower price of their COVID-19 vaccines amid criticism from various states who accused the companies of profiteering during such a major crisis.
Now the two companies are expected to come up with revised pricing for their vaccines.
The Hyderabad-based Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at Rs 1,200 per dose for private hospitals.
The Pune-based Serum Institute of India (SII), the world's largest vaccine maker in terms of volume, has announced a price of Rs 400 per dose for its COVID-19 vaccine, 'Covishield', for state governments and Rs 600 per dose for private hospitals.
A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccine’s potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research.
#IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity
~HT.97~PR.152~
Five Navagraha idols were found vandalized at a Hanuman temple in Shamshabad, Hyderabad, prompting protests from locals. Police detained a suspect and are.. IndiaTimes
Zomato CEO Deepinder Goyal on Monday said the company has delisted the vendor responsible for putting "incorrect packaging date" on mushroom packets that were.. DNA
The BJP and the Maha Vikas Aghadi faced rebel candidates in the Maharashtra assembly polls, despite attempts to consolidate support. Several high-profile.. IndiaTimes
Residents of the locality have demanded strict action against the accused driver and warned of a protest if the police fail to apprehend him, it was stated. DNA
Delhi Chief Minister Arvind Kejriwal informed that Delhi government has asked both vaccine manufacturing companies, Bharat Biotech and Serum Institute of India for 67 lakh doses each in next 3 months...
Ahead of vaccination drive for citizens between 18-44 years, Delhi Chief Minister Arvind Kejriwal on April 30 requested people to not stand in queues outside vaccine centres on May 01 as Delhi..
Karnataka Health Minister K Sudhakar indicated delay in phase 3 of COVID vaccine inoculation, which is supposed to get started from May 01 and also requested people from 18-44 age group to refrain from..
![Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis [Video]](https://video.newsserve.net/300/v/20240912/1387343466-Cure-or-Threat-Wuhan-Lab-New-Intranasal.jpg)
![Have asked for 67 lakh doses each from both vaccine manufacturing companies: CM Kejriwal [Video]](https://video.newsserve.net/300/v/20210430/2104300853-Have-asked-for-67-lakh-doses-each-from.jpg)
![Don't visit vaccination centre, haven't received vaccines: CM Kejriwal [Video]](https://video.newsserve.net/300/v/20210430/2104301050-Don-visit-vaccination-centre-haven-received.jpg)
![Phase 3 vaccination drive to delay in Karnataka due to vaccine shortage [Video]](https://video.newsserve.net/300/v/20210430/2104301050-Phase-vaccination-drive-to-delay-in-Karnataka.jpg)
